Zusammenfassung
Die altersabhängige Makuladegeneration (AMD) ist eine progrediente Erkrankung des zentralen Netzhaut-/Pigmentepithel-/Aderhaut-Komplexes. Eine AMD liegt vor, wenn eine oder mehrere der nachgenannten Veränderungen im Bereich der Makula vorliegen:
-
weiche Drusen: gelbliche Ablagerungen, ≥63 µm zwischen dem retinalen Pigmentepithel und der Bruch-Membran,
-
Hyper- oder Hypopigmentationen des retinalen Pigmentepithels,
-
geographische Atrophie des retinalen Pigmentepithels: scharf begrenzte Gebiete einer Atrophie des retinalen Pigmentepithels und der Choriokapillaris,
-
neovaskuläre Makuladegeneration: choroidale Neovaskularisation, seröse oder hämorrhagische Abhebung des retinalen Pigmentepithels oder spätere Vernarbung der Makula in Form einer disziformen Narbe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 107: 2224–2232
Ajani UA et al. (1999) A prospective study of alcohol consumption and the risk of age-related macular degeneration. Ann Epidemiol 9: 172–177
Allikmets R (2000) Further evidence for an association of ABCR alleles with age-related macular degeneration.The International ABCR Screening Consortium. Am J Hum Genet 67: 487–491
Allikmets R et al. (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15: 236–246
Anderson DH et al. (2001) Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 131: 767–781
AREDS Report no.8 (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119: 1417–1436
Beatty Set (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Sury Ophthalmol 45: 115–134
Bird AC et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration.The International ARM Epidemiological Study Group. Sury Ophthalmol 39: 367–374
Blumenkranz MS et aí. (1986) Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 93: 552–558
Bressler NM et al. (1989) The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol 107: 847–852
Bressler NM et aí. (1995) Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities.Waterman study. Arch Ophthalmol 113: 301–308
Cai Jet (2000) Oxidative damage and protection of the RPE. Prog Retin Eye Res 19: 205–221
Chang B et al. (1995) Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration. Ophthalmology 102: 1380–1386
Cho E et al. (2000) Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 118: 681–688
Cho E et al. (2001) Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol 11: 328–336
Christen WG et al. (1996) A prospective study of cigarette smoking and risk of age-related macular degeneration in men.JAMA 276: 1147–1151
Christen WG et al. (1999) Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol 149: 476–484
Christen WG et al. (2001) Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol 119: 1143–1149
Cruickshanks KJ, Klein R, Klein BE (1993) Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111: 514–518
Cruickshanks KJ et al. (1997) The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 115: 242–250
Cruickshanks KJ et al. (2001) Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study. Arch Ophthalmol 119: 246–250
Curcio CA et al. (2001) Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci 42: 265–274
Delaney WV, Oates RP (1982) Senile macular degeneration: a preliminary study. Ann Ophthalmol 14: 21–24
De la Paz MA et al. (1997a) Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 38: 1060–1065
De la Paz MA et al. (1997b) Phenotypic heterogeneity in families with age-related macular degeneration. Am J Ophthalmol 124: 331–343
Delcourt C et al. (1998) Smoking and age-related macular degeneration.The POLA Study. Pathologies oculaires liees a l’age. Arch Ophthalmol 116: 1031–1035
Delcourt C et al. (1999a) Associations of antioxidant enzymes with cataract and age-related macular degeneration.The POLA Study. Pathologies oculaires liees a l’age. Ophthalmology 106: 215–222
Delcourt C et al. (1999b) Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies oculaires liees a l’age. Arch Ophthalmol 117: 1384–1390
Diaz MN et al. (1997) Antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408–416
Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227–2253
Eye Disease Case-Control Study Group (1993) Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 111: 104–109
Foran S, Mitchell P, Wang Jl (2002) Five-year change in visual acuity and incidence of visual impairment.Ophthalmology 110: 41–50
Friedman DS et al. (1999) Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 106: 1049–1055
Friedman E (1970) Choroidal blood flow. Pressure-flow relationships. Arch Ophthalmol 83: 95–99
Friedman E (2000) The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130: 658–663
Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithel ium. Am 1 Ophthalmol 63 [suppl]: 1–139
Gass JD (1973) Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90: 206–217
Gibson JM, Rosenthal AR, Lavery J (1985) A study of the prevalence of eye disease in the elderly in an English community.Trans Ophthalmol Soc U K 104: 196–203
Goldberg L (1988) Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700–710
Gorin MB etal. (2001) Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within 1q31 and 17q25 regions. Am J Hum Genet 46, abstr 2117
Gregor Z, Bird AC,Chisholm ICH (1977) Senile disciform macular degeneration in the second eye. Br J Ophthalmol 61: 141–147
Guymer RH et al. (2001) Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 119: 745–751
Hammond Cl (2001) Genetic influence on early age-related macular degeneration: a population-based twin study. Invest Ophthalmol Vis Sci 42:5310, abstr 1670
Heiba IM et al. (1994) Sibling correlations and segregation analysis of age-related maculopathy:the Beaver Dam Eye Study. Genet Epidemiol 11: 51–67
Hirvela H et al. (1996) Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103: 871–877
Holz FG et al. (1994a) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 101: 1522–1528
Holz FG et al. (1994b) Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration. Am J Ophthalmol 117: 19–23
Hyman LG et al. (1983) Senile macular degeneration: a case-control study. Am J Epidemiol 118: 213–227
Hyman L et al. (2000) Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118: 351–358
Ikeda T et al. (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am 1 Ophthalmol 132: 191–195
Jonasson F,Thordarson K (1987) Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol 182 [suppl]: 40–43
Kahn HA et aí. (1977) The Framingham Eye Study.I.Outline and major prevalence findings. Am 1 Epidemiol 106: 17–32
Kimura K et al. (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130: 769–773
Klaver CC et al. (1998a) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116: 1646–1651
Klaver CC et al. (1998b) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63: 200–206
Klaver CC et al. (1999) Is age-related maculopathy associated with Alzheimer’s disease?The Rotterdam Study.Am J Epidemiol 150: 963–968
Klaver CC et al. (2001) Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42: 2237–2241
Klein BE, Klein R (1982) Cataracts and macular degeneration in older Americans. Arch Ophthalmol 100: 571–3
Klein BE et al. (1994) Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study.Trans Am Ophthalmol Soc 92: 289–295
Klein BE, Klein R, Lee KE (2000) Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. Am J Ophthalmol 130: 322–326
Klein BE et al. (2001) Risk of incident age-related eye diseases in people with an affected sibling:The Beaver Dam Eye Study.Am J Epidemiol 154: 207–211
Klein ML, Mauldin WM,StoumbosVD (1994) Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 112: 932–937
Klein ML et al. (1998) Age-related macular degeneration.Clinical features in a large family and linkage to chromosome 1g. Arch Ophthalmol 116: 1082–1088
Klein R et al. (1991) The Wisconsin age-related maculopathy grading system. Ophthalmology 98: 1128–1134
Klein R, Klein BE, Moss SE (1992a) Diabetes, hyperglycemia, and age-related maculopathy.The Beaver Dam Eye Study. Ophthalmology 99: 1527–1534
Klein R, Klein BE, Linton KL (1992b) Prevalence of age-related maculopathy.The Beaver Dam Eye Study.Ophthalmology 99: 933–943
Klein R, Klein BE, FrankeT (1993) The relationship of cardiovascular disease and its risk factors to age-related maculopathy.The Beaver Dam Eye Study. Ophthalmology 100: 406–414
Klein R et al. (1994) Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112: 191–196
Klein R et al. (1995a) The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36: 182–191
Klein R, Rowland ML, Harris MI (1995b) Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 102: 371–381
Klein R et al. (1997a) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 7–21
Klein R, Klein BE, Jensen SC (1997b) The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 1804–1812
Klein R et al. (1998a) The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116: 506–513
Klein R, Klein BE, Moss SE (1998b) Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 147: 103–110
Klein R et al. (1998c) Is age-related maculopathy related to hearing loss? Arch Ophthalmol 116: 360–365
Klein R et al. (1999a) Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey Ill. Ophthalmology 106: 1056–1065
Klein R et al. (1999b) Prevalence of age-related maculopathy in the atherosclerosis risk in communities study. Arch Ophthalmol 117: 1203–1210
Klein R et al. (2001) Medication use and the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Arch Ophthalmol 119: 1354–1359
Kohner EM, Patel V, Rassam SM (1995) Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 44: 603–607
Kornzweig AL (1977) Changes in the choriocapillaris associated with senile macular degeneration. Ann Ophthalmol 9: 759–762
Leibowitz HM et al. (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Sury Ophthalmol 24 [suppl]: 335–610
Liu IY, White L, LaCroix AZ (1989) The association of age-related macular degeneration and lens opacities in the aged. Am 1 Public Health 79: 765–769
Lotery AJ et al. (2000) Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci 41: 1291–1296
Macular Photocoagulation Study Group (1993) Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111: 1189–1199
Macular Photocoagulation Study Group (1997) Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 115: 741–747
Maltzman BA, Mulvihill MN,Greenbaum A (1979) Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 11: 1197–1201
Mares-Perlman JA et al. (1995) Dietary fat and age-related maculopathy. Arch Ophthalmol 113: 743–748
Mares-Perlman JA et al. (1996) Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114: 991–997
Mares-Perlman JA et al. (2001) Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol 153: 424–432
Martinez GS et al. (1982) Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol 94: 181–189
Mata NL et al. (2001) Delayed dark-adaptation and lipofuscin accumulation in abcr+/-mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 42: 1685–1690
McCarty CA et al. (2001) Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119: 1455–1462
Meyers SM, Greene T, Gutman FA (1995) A twin study of age-related macular degeneration. Am J Ophthalmol 120: 757–766
Mitchell P,Smith W, Wang JJ (1998) Iris color, skin sun sensitivity, and age-related maculopathy.The Blue Mountains Eye Study. Ophthalmology 105: 1359–1363
Mitchell RA (1993) Prevalence of age related maculardegeneration in persons aged 50 years and over resident in Australia.) Epidemiol Community Health 47: 42–45
Montalescot G et al. (1998) Fibrinogen as a risk factor for coro- nary heart disease. Eur Heart J 19 [suppl H]: H11–17
Mullins RF et aí. (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J 14: 835–846
Newsome DA et al. (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106: 192–198
Paetkau ME et al. (1978) Senile disciform macular degeneration and smoking.Can J Ophthalmol 13: 67–71
Pagliarini S et al. (1997) Age-related macular disease in rural southern Italy. Arch Ophthalmol 115: 616–622
Pang CP (2000)The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214:289–291
Piquet Bet (1993) Age-related Bruch’s membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol 77: 400–403
Pollack A et aí. (1996) Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology 103: 1546–1554
Pryor WA et al. (1983) The radicals in cigarette tar:their nature and suggested physiological implications. Science 220: 425–427
Ritter LL et al. (1995) Alcohol use and age-related maculopathy in the Beaver Dam Eye Study. Am J Ophthalmol 120: 190–196
Rosenthal FS et al. (1991) Ocular and facial skin exposure to ultraviolet radiation in sunlight:a personal exposure model with application to a worker population. Health Phys 61: 77–86
Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd ed. Lippincott-Raven, Philadelphia, xiii, p 737
Roy M, Kaiser-Kupfer M (1990) Second eye involvement in age-related macular degeneration:a four-year prospective study. Eye 4: 813–818
Ryan SJ, Mitt! RN, Maumenee AE (1980)The disciform response: an historical perspective. Albrecht Von Graefes Arch Klin Exp Ophthalmol 215: 1–20
Sandberg MA et al. (1993) Hyperopia and neovascularization in age-related macular degeneration. Ophthalmology 100: 1009–1013
Sandberg MA et al. (1998) High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105: 441–447
Sanders TA et al. (1993) Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 57: 428–433
Sarraf D et al. (1999) Long-term drusen study. Retina 19: 513–519
Schachat AP et al. (1995) Features of age-related macular degeneration in a black population.The Barbados Eye Study Group. Arch Ophthalmol 113: 728–735
Schaumberg DA et aí. (2001) Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 119: 1259–1265
Schectman G, Byrd JC, Gruchow HW (1989) The influence of smoking on vitamin C status in adults.Am J Public Health 79: 158–162
Schmidt S et al. (2000) Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6: 287–293
Seddon JM et al. (1994) Dietary carotenoids,vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.JAMA 272: 1413–1420
Seddon JM et al. (1996) A prospective study of cigarette smoking and age-related macular degeneration in women. Jama 276: 1141–1146
Seddon JM,Ajani UA,Mitchell BD (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123: 199–206
Seddon JM et al. (2001) Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119: 1191–1199
Silvestri G,Johnston PB, Hughes AE (1994) Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 8: 564–568
Smiddy WE, Fine SL (1984) Prognosis of patients with bilateral macular drusen. Ophthalmology 91: 271–277
Smith W, Mitchell P (1996) Alcohol intake and age-related maculopathy. Am J Ophthalmol 122: 743–745
Smith W, Mitchell P,Leeder SR (1996) Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 114: 1518–1523
Smith W, Mitchell P, Wang JJ (1997a) Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 25 [suppl 1]: S13–15
Smith W, Mitchell P, Rochester C (1997b) Serum beta carotene, alpha tocopherol, and age-related maculopathy: The Blue Mountains Eye Study. Am J Ophthalmol 124: 838–840
Smith W et al. (1999) Dietary antioxidants and age-related maculopathy: The Blue Mountains Eye Study. Ophthalmology 106: 761–767
Smith W et al. (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy:The Blue Mountains Eye Study. Arch Ophthalmol 116: 583–587
Smith W, Mitchell P, Leeder SR (2000) Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol 118: 401–404
Smith W et al. (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108: 697–704
Solberg Y, Rosner M, Belkin M (1998) The association between cigarette smoking and ocular diseases. Sury Ophthalmol 42: 535–547
Souied EH et al. (1998) The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125: 353–359
Sperduto RD, Hiller Rand R (1986) Systemic hypertension and age-related maculopathy in the Framingham Study.Arch Ophthalmol 104: 216–219
Sperduto RD, Ferris FL, Kurinij N (1990) Do we have a nutritional treatment for age-related cataract or macular degeneration? Arch Ophthalmol 108: 1403–1405
Stone EM et al. (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22: 199–202
Stryker WS et al. (1988) The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127: 283–296
Stur M et al. (1996) Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 1225–1235
Sunness JS et al. (1997) Visual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuity. Ophthalmology 104: 1677–1691
Sunness JS (1999)The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 106:910–919
Sunness JS, Applegate CA, Gonzalez-Baron J (2000) Improvement of visual acuity over time in patients with bilateral geographic atrophy from age-related macular degeneration. Retina 20: 162–169
TAP Study Group (1999) Treatment of age-related macular degeneration with photodynamic therapy (TAP). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials–TAP report. Arch Ophthalmol 117: 1329–1345
Taylor HR et al. (1990) Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc 88: 163–173
The Eye Disease Case-Control Study Group (1992) Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110: 1701–1708
Tilanus MA et al. (2000) Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 238: 482–485
Tso MO, Woodford BJ (1983) Effect of photic injury on the retinal tissues. Ophthalmology 90: 952–963
Van den Langenberg GM et al. (1998) Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am 1 Epidemiol 148: 204–214
Van der Schaft TL et al. (1994) Increased prevalence of disci-form macular degeneration after cataract extraction with implantation of an intraocular lens. Br J Ophthalmol 78: 441–445
Van Newkirk MR et al. (2000) The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 107: 1593–1600
Vidaurri JS et al. (1984) Association between drusen and some of the risk factors for coronary artery disease.Ophthalmologica 188: 243–247
Vinding T (1989) Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals.Acta Ophthalmol 67: 609–616
Vinding T (1990) Pigmentation of the eye and hair in relation to age-related macular degeneration.An epidemiological study of 1000 aged individuals. Acta Ophthalmol 68: 53–88
Vinding T et al. (1992) Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol 70: 66–72
Vingerling JR et al. (1995a) The prevalence of age-related maculopathy in the Rotterdam Study [see comments]. Ophthalmology 102: 205–210
Vingerling JR et al. (1995b) Macular degeneration and early menopause: a case-control study. Bmj 310: 1570–1571
Vingerling JR et al. (1995c) Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142: 404–409
Vingerling JR et al. (1996) Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 114: 1193–1196
Wang JJ, Mitchell P, Smith W (1998) Refractive error and age-related maculopathy: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci 39: 2167–2171
Webster AR et al. (2001) An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci 42: 1179–1189
Weeks DE et al. (2000) A full genome scan for age-related maculopathy. Hum Mol Genet 9: 1329–1349
Weiter JJ (1985) Relationship of senile macular degeneration to ocular pigmentation. Am 1 Ophthalmol 99: 185–187
West Set (1994) Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 112: 222–227
West SK et al. (1989) Exposure to sunlight and other risk factors for age-related macular degeneration.Arch Ophthalmol 107: 875–879
Witteman JC et al. (1989) Increased risk of atherosclerosis in women after the menopause. BMJ 298: 642–644
Young RW (1988) Solar radiation and age-related macular degeneration. Sury Ophthalmol 32: 252–269
Zemel PC, Sowers JR (1990) Relation between lipids and atherosclerosis: epidemiologic evidence and clinical implications.Am J Cardiol 66: 71–121
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klaver, C.C.W., van Leeuwen, R., Vingerling, J.R., de Jong, P.T.V.M. (2004). Epidemiologie. In: Altersabhängige Makuladegeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05681-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-05681-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-05682-0
Online ISBN: 978-3-662-05681-3
eBook Packages: Springer Book Archive